CVS Health (CVS) Q1 2024 Earnings
CVS Health reported Q1 2024 revenue of $88.4B, missed analyst consensus of $89.3B by $891.4M. Diluted EPS came in at $1.31, missed the $1.70 consensus by $0.39. CVS Health reports across 3 business segments, led by Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about CVS Health's Q1 2024 earnings report.
CVS Health (CVS) reported Q1 2024 earnings on May 1, 2024 before market open.
CVS Health reported revenue of $88.4B and diluted EPS of $1.31 for Q1 2024.
Revenue missed the consensus estimate of $89.3B by $891.4M. EPS missed the consensus estimate of $1.70 by $0.39.
You can read the 10-Q periodic report (0000064803-24-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.